Tudor Investment Corp ET AL purchased a new position in shares of AdvanSix Inc. (NYSE:ASIX - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 11,010 shares of the company's stock, valued at approximately $314,000.
Other hedge funds have also recently modified their holdings of the company. AlphaQuest LLC bought a new stake in shares of AdvanSix during the 4th quarter valued at $94,000. KLP Kapitalforvaltning AS bought a new position in shares of AdvanSix in the fourth quarter worth about $137,000. GeoWealth Management LLC purchased a new stake in shares of AdvanSix during the fourth quarter worth about $221,000. Foundations Investment Advisors LLC bought a new stake in AdvanSix during the 4th quarter valued at approximately $223,000. Finally, Envestnet Asset Management Inc. purchased a new position in AdvanSix in the 4th quarter worth approximately $228,000. Institutional investors own 86.39% of the company's stock.
Insider Activity at AdvanSix
In related news, SVP Achilles B. Kintiroglou sold 4,000 shares of the stock in a transaction that occurred on Tuesday, April 1st. The shares were sold at an average price of $22.24, for a total value of $88,960.00. Following the completion of the transaction, the senior vice president now directly owns 36,363 shares of the company's stock, valued at $808,713.12. This trade represents a 9.91 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 5.60% of the stock is owned by corporate insiders.
AdvanSix Trading Down 0.6 %
ASIX opened at $23.13 on Friday. The company has a debt-to-equity ratio of 0.25, a quick ratio of 0.49 and a current ratio of 1.08. The stock's 50 day moving average price is $22.14 and its 200-day moving average price is $27.22. AdvanSix Inc. has a one year low of $18.44 and a one year high of $33.00. The stock has a market cap of $620.18 million, a price-to-earnings ratio of 14.37 and a beta of 1.59.
AdvanSix (NYSE:ASIX - Get Free Report) last issued its earnings results on Friday, February 21st. The company reported $0.03 EPS for the quarter, topping analysts' consensus estimates of ($0.37) by $0.40. The business had revenue of $329.06 million for the quarter, compared to the consensus estimate of $377.15 million. AdvanSix had a net margin of 2.91% and a return on equity of 6.26%. On average, equities analysts forecast that AdvanSix Inc. will post 4 EPS for the current year.
AdvanSix Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, May 27th. Investors of record on Tuesday, May 13th will be paid a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a dividend yield of 2.77%. The ex-dividend date is Tuesday, May 13th. AdvanSix's dividend payout ratio (DPR) is currently 20.51%.
Analyst Upgrades and Downgrades
ASIX has been the topic of several research analyst reports. UBS Group set a $35.00 price target on shares of AdvanSix in a research note on Tuesday, March 18th. StockNews.com downgraded AdvanSix from a "buy" rating to a "hold" rating in a research report on Monday, March 24th. Finally, Piper Sandler cut AdvanSix from an "overweight" rating to a "neutral" rating and cut their price target for the company from $35.00 to $26.00 in a report on Monday, April 7th.
Get Our Latest Stock Analysis on ASIX
About AdvanSix
(
Free Report)
AdvanSix Inc engages in the manufacture and sale of polymer resins in the United States and internationally. It offers Nylon 6, a polymer resin, which is a synthetic material used to produce fibers, filaments, engineered plastics, and films. The company also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone that are used in the production of adhesives, paints, coatings, solvents, herbicides, and engineered plastic resins, as well as other intermediate chemicals, including phenol, monoisopropylamine, dipropylamine, monoallylamine, alpha-methylstyrene, cyclohexanone, methyl ethyl ketoxime, acetaldehyde oxime, 2-pentanone oxime, cyclohexanol, sulfuric acid, ammonia, and carbon dioxide.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider AdvanSix, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AdvanSix wasn't on the list.
While AdvanSix currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.